Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden

被引：0
|
作者：
Johan Lundberg
Martin Höglund
Magnus Björkholm
Örjan Åkerborg
机构：
[1] MSD Sweden (AB),Outcomes Research
[2] University Hospital,Division of Hematology, Department of Medical Science
[3] Karolinska University Hospital Solna,Department of Medicine
[4] Optum Insight,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Acute Myeloid Leukemia; Fluconazole; Itraconazole; Invasive Aspergillosis; Acute Myeloid Leukemia Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：483 / 489
页数：6
相关论文
共 50 条
  • [1] Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
    Santiago Grau
    Rafael de la Cámara
    Francisco J Sabater
    Isidro Jarque
    Enric Carreras
    Miguel A Casado
    Miguel A Sanz
    BMC Infectious Diseases, 12
  • [2] Cost-Effectiveness of Posaconazole versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infections among Neutropenic Patients in the United States
    O'Sullivan, Amy K.
    Pandya, Ankur
    Papadopoulos, George
    Thompson, David
    Langston, Amelia
    Perfect, John
    Weinstein, Milton C.
    VALUE IN HEALTH, 2009, 12 (05) : 666 - 673
  • [3] Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis
    Zhao, Ying Jiao
    Khoo, Ai Leng
    Tan, Gloria
    Teng, Monica
    Tee, Caroline
    Tan, Ban Hock
    Ong, Benjamin
    Lim, Boon Peng
    Chai, Louis Yi Ann
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 376 - 386
  • [4] Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies
    Hachem, Ray
    Assaf, Andrew
    Numan, Yazan
    Shah, Pankil
    Jiang, Ying
    Chaftari, Anne-Marie
    Raad, Issam I.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (03) : 384 - 388
  • [5] Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
    de la Camara, R.
    Jarque, I.
    Sanz, M. A.
    Grau, S.
    Casado, M. A.
    Sabater, F. J.
    Carreras, E.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 925 - 932
  • [6] Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT
    R de la Cámara
    I Jarque
    M A Sanz
    S Grau
    M A Casado
    F J Sabater
    E Carreras
    Bone Marrow Transplantation, 2010, 45 : 925 - 932
  • [7] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
    Dranitsaris, George
    Khoury, Haytham
    SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1807 - 1813
  • [8] Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis
    George Dranitsaris
    Haytham Khoury
    Supportive Care in Cancer, 2011, 19 : 1807 - 1813
  • [9] Intravenous-oral itraconazole versus oral posaconazole in preventing invasive fungal diseases for acute leukemia patients
    Liu, Li
    Pei, Xiaolei
    Ma, Runzhi
    He, Yi
    Zhang, Rongli
    Wei, Jialin
    Ma, Qiaoling
    Zhai, Weihua
    Pang, Aiming
    Jiang, Erlie
    Han, Mingzhe
    Yang, Donglin
    Feng, Sizhou
    BLOOD SCIENCE, 2023, 5 (02): : 106 - 110
  • [10] Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients
    Lamy, T
    Bernard, M
    Courtois, A
    Jacquelinet, C
    Chevrier, S
    Dauriac, C
    Grulois, I
    Guiguen, C
    Le Prise, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (1-2) : 163 - 174
12345